These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Low molecular weight heparins in the initial treatment of deep vein thrombosis. Volteas SK; Kalodiki E; Nicolaides AN Int Angiol; 1996 Mar; 15(1):67-74. PubMed ID: 8739540 [TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival. Nishioka J; Goodin S J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108 [TBL] [Abstract][Full Text] [Related]
36. Treatment of deep vein thrombosis using low-molecular-weight heparins. Groce JB Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662 [TBL] [Abstract][Full Text] [Related]
37. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes. Nguyen-Ho P; Levine GN Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429 [TBL] [Abstract][Full Text] [Related]
38. [State of the art: low-molecular-weight heparin and beyond]. Cimminiello C; Casali G; Vitali L Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343 [TBL] [Abstract][Full Text] [Related]
39. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis? Brewer D J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370 [TBL] [Abstract][Full Text] [Related]